Physician profile
Michael S Hisey
NPI 1346283348
$363,462.87
in general payments reported to CMS, 2019-2025
33 companies · $71K in 2025
The $71K reported for 2025 was more than what 90% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99K · 2020: $49K · 2021: $24K · 2022: $53K · 2023: $30K · 2024: $38K · 2025: $71K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $71K · Royalty Or License: $45K · Travel and Lodging: $16K · Food and Beverage: $5,618 · Honoraria: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $71,252.00 |
| Royalty Or License | $45,119.97 |
| Travel and Lodging | $16,394.96 |
| Food and Beverage | $5,618.39 |
| Honoraria | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $167,270.20 | 2019-2022 | |
| Zimvie INC. | $59,230.45 | 2022-2023 | |
| Centinel Spine, LLC | $58,499.03 | 2019-2025 | Prodisc L, Prodisc C |
| Highridge Medical LLC | $25,213.00 | 2024-2025 | Roi-A, Pathfinder Nxt |
| Orthofix Medical, INC. | $13,202.80 | 2019-2025 | Mariner, Miscellaneous, 7d Surgical System |
| Clariance, INC. | $12,867.30 | 2023-2025 | Idys-Alif, Idys-Llif 3dti, Idys-Alif Zp 3dti |
| Innovasis INC | $6,921.08 | 2019-2020 | |
| Cerapedics INC. | $6,533.41 | 2019-2022 | |
| Providence Medical Technology, INC. | $6,010.99 | 2021-2023 | |
| 4web, INC. | $1,610.28 | 2019-2021 | |
| Seaspine Orthopedics Corporation | $1,340.32 | 2019-2022 | |
| Osteocentric Technologies, INC. | $714.98 | 2023-2024 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Spinal Elements, INC. | $554.77 | 2020-2023 | |
| Curiteva, INC. | $538.16 | 2019-2022 | |
| Kuros Biosciences USA, INC | $484.90 | 2023-2025 | Magnetos |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Degen Medical, INC. | $470.51 | 2024-2025 | Alif |
| Integrity Implants INC. | $433.26 | 2021-2022 | |
| Bioventus LLC | $263.58 | 2024 | Bonescalpel & Sonicone (O.R.) |
| Globus Medical, INC. | $244.62 | 2024-2025 | Acp, Cohere, Rise |
| Painteq LLC | $226.24 | 2023 | Painteq |
| Nuvasive, INC. | $190.67 | 2019 | |
| Spineology INC. | $138.39 | 2019 | |
| Spinevision Sas | $109.22 | 2025 | |
| Depuy Synthes Sales INC. | $100.90 | 2024 | Viper, Teligen |
| Medtronic, INC. | $86.48 | 2024-2025 | Stealthstation S8 Platform, Inceptiv |
| Ctl Medical Corporation | $44.34 | 2022 | |
| Axis Spine Technologies INC. | $40.51 | 2023 | Alif |
| Merit Medical Systems INC | $31.57 | 2020 | |
| Ethicon US, LLC | $23.24 | 2021 | |
| Expanding Innovations, INC. | $23.00 | 2024 | X-Pac |
| Boston Scientific Corporation | $16.01 | 2025 | Enhance Transcarotid Peripheral Access Kit |
| Intrinsic Therapeutics | $14.41 | 2020 | |
| Saluda Medical Americas, INC. | $14.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,026,048.67 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hisey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.